Wilson Sonsini Goodrich & Rosati represented Parvus in the transaction Parvus Therapeutics, a biopharmaceutical company focused on the development of disease-specific immunoregulatory medicines to treat autoimmune…
Parvus Therapeutics’ Agreement with Genentech
